Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]

INTRODUCTION: Mucin 1 (MUC1) is a high molecular weight glycoprotein overexpressed on adenocarcinoma cells and is a target for immunotherapy protocols. To date, clinical trials against MUC1 have included advanced cancer patients. Herein, we report a trial using early stage breast cancer patients and...

Descripción completa

Detalles Bibliográficos
Autores principales: Apostolopoulos, Vasso, Pietersz, Geoffrey A, Tsibanis, Anastasios, Tsikkinis, Annivas, Drakaki, Heleni, Loveland, Bruce E, Piddlesden, Sara J, Plebanski, Magdalena, Pouniotis, Dodie S, Alexis, Michael N, McKenzie, Ian F, Vassilaros, Stamatis
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557739/
https://www.ncbi.nlm.nih.gov/pubmed/16776849
http://dx.doi.org/10.1186/bcr1505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557739/
https://www.ncbi.nlm.nih.gov/pubmed/16776849
http://dx.doi.org/10.1186/bcr1505

Ejemplares similares